Tag: kinetics

Nyheter

Find out: Why bridge the existing gap between biochemical and cell based assays?

2011-11-16 09:30 One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.

Attana appears in Swedish Life Science

2011-11-02 09:03 "Swedish Life Science is a comprehensive introduction to an industry that employs some 40,000 people in Sweden, accounts for 20 per cent of Swedish net export worth over over SEK 40 billion, and is fast becoming a cornerstone of the national economy."

Tecan Journal- corporate news!

2011-05-31 09:00 Find out latest news, events and collaborations from Tecan- read the interview with Attana's Sales and Marketing Manager, Gabriela Suhoschi about Attana's collaboration with Tecan's on page 5!

Visa alla 4 nyheter »

Evenemang

Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells

2012-04-04 09:00 "A novel tool for characterization of molecular interactions on cell surfaces"- presentation by Teodor Aastrup, Attana CEO.

Tid: 2012-06-25 - 2012-06-27
Plats: Santa Marina Hotel, Mykonos, Greece

Bilder

Attana Cell 200 biosensor-  Label free, real time kinetics on cells

2010-02-22 10:05 Cell and biochemical assays Analyte/ligand types: - Adherent cells - Suspension cells - Fixed and non-fixed cells - Crude samples - Proteins, antibodies, carbohydrates - Viruses, bacteria Applications: - Kinetics on cells - Cell capturing - Detailed kinetics - Concentration determination - Competition assay - Epitope mapping - Off-rate selection - Aggregation characterization

Dokument

2011-06-20 08:28 Two experiments with two distinct purposes were performed on the Attana Cell 200. The first experiment intended to find a diagnostic tool to test tumors after surgery to see if they are metastatic. The second experiment tested a herceptin conjugate designed for targeted immunotherapy. Both results showed that the Attana Cell 200 may help lowering clinical stage failure rates.

2011-05-24 09:00 Attana Cell 200 - Bridging the gap between traditional biosensors and cell-based assays! Drug development is costly and risky and the need for technologies that accelerate the process of drug discovery becomes increasingly urgent. This paper shows four instances of how the Attana Cell 200 biosensor provides data enhancing the ability to select the right drug candidates earlier in the process.

2011-04-18 09:52 The data obtained from QCM analyses are firstly qualitative, delivering information about specificity and selectivity, and quantitative, delivering exact thermodynamic and kinetic parameters of interactions. See the difference in this poster!

Visa alla 4 dokument »